Hydroxyurea Proves Safe for Children with Sickle Cell Anaemia in Landmark African Study
A decade-long REACH trial analysis across four African countries finds hydroxyurea does not raise infection risk in children with sickle ...
A decade-long REACH trial analysis across four African countries finds hydroxyurea does not raise infection risk in children with sickle ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.